Skip to search formSkip to main contentSkip to account menu

Stomatitis

Known as: MUCOSITIS ORAL, Stomatitides, Inflammation of the mouth 
INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.
National Institutes of Health

Related topics

Related topics

34 relations

Narrower (5)

Aphthous StomatitisCheilitisGingivostomatitisOral Mucositis
Dermatologic disordersHead and neck structureINTERLEUKIN 1 RECEPTOR ANTAGONIST DEFICIENCYIn Blood

Broader (5)

Gastrointestinal DiseasesInflammationInflammatory disease of mucous membraneMouth Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Mucositis: The impact, biology and therapeutic opportunities of oral mucositis.
Highly Cited
2007
Highly Cited
2007
Clinical Practice Guidelines for the Prevention and Treatment of Mucositis
Dorothy M. Keefe, MD Mark M. Schubert, DDS, MSD Linda S. Elting, DrPH Stephen T. Sonis, DMD, DMSc Joel B. Epstein, DMD, MSD… 
Highly Cited
2003
Highly Cited
2003
Reassessing the presence of Candida albicans in denture-related stomatitis.
OBJECTIVE The aim of this study was to reevaluate the link between Candida albicans and denture-related stomatitis according to a… 
Highly Cited
2003
Highly Cited
2003
The burdens of cancer therapy
Mucositis is a common but poorly studied problem among patients with solid tumors. The authors examined the clinical and economic… 
Highly Cited
2002
Highly Cited
2002
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?
To the authors' knowledge, the significance of postoperative adjuvant chemotherapy in pancreaticobiliary carcinoma has not yet… 
Highly Cited
2001
Highly Cited
2001
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.
PURPOSE To explore the relationship between oral mucositis and selected clinical and economic outcomes in blood and marrow… 
Highly Cited
2001
Highly Cited
2001
Multicenter, Phase II study of capecitabine in taxane‐pretreated metastatic breast carcinoma patients
Capecitabine is an oral, tumor‐targeted fluoropyrimidine carbamate with high activity in metastatic breast carcinoma and in… 
Highly Cited
2001
Highly Cited
2001
Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment
Chemotherapy‐ and radiotherapy‐induced oral mucositis represents a therapeutic challenge frequently encountered in cancer… 
Highly Cited
1995
Highly Cited
1995
Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence…
PURPOSE To define the maximum-tolerated dose (MTD) and better tolerated sequence of paclitaxel by 3-hour infusion plus bolus… 
Review
1994
Review
1994
Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.
Paclitaxel is a new anticancer agent with a novel mechanism of action. It promotes polymerisation of tubulin dimers to form… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)